Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Andrew

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
American Journal of Respiratory and Critical Care Medicine|May 15, 2024
Pulmonary Hypertension and Anastrozole (PHANTOM): A Randomized, Double-Blind, Placebo-Controlled TrialSteven M Kawut, Rui Feng, Susan S Ellenberg, et al.
BMJ Open|September 16, 2024
Preterm birth as a determinant of neurodevelopment and cognition in children (PRENCOG): protocol for an exposure-based cohort study in the UKJames P Boardman, Ruth Andrew, Mark E Bastin, et al.
British Journal of Pharmacology|December 28, 2025
Pharmacological inhibition of hydroxysteroid 11-beta dehydrogenase type 1 (11-βHSD1) after myocardial infarction preserves cardiac function in a translational mini-pig modelSara Al Disi, Raimondo Ascione, Shazia Khan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 11, 2013
11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosisTiina Kipari, Patrick W F Hadoke, Javaid Iqbal, et al.
Hepatology (Baltimore, Md.)|May 15, 2020
Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2)Nadine Al-Naamani, Michael J Krowka, Kimberly A Forde, et al.
Scientific Reports|September 8, 2017
Carbonyl reductase 1 catalyzes 20β-reduction of glucocorticoids, modulating receptor activation and metabolic complications of obesityRuth A Morgan, Katharina R Beck, Mark Nixon, et al.
Clinical Endocrinology|January 17, 2024
Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19Kerri Devine, Clark D Russell, Giovanny R Blanco, et al.
Science Signaling|May 5, 2026
LIPID MAPS: Powering discovery in lipidomicsLauren Cockayne, Matthew J Conroy, Chetin Baloglu, et al.
Science Signaling|May 20, 2025
Technical recommendations for analyzing oxylipins by liquid chromatography-mass spectrometryNils Helge Schebb, Nadja Kampschulte, Gerhard Hagn, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
American Journal of Respiratory and Critical Care Medicine|May 15, 2024
Pulmonary Hypertension and Anastrozole (PHANTOM): A Randomized, Double-Blind, Placebo-Controlled TrialSteven M Kawut, Rui Feng, Susan S Ellenberg, et al.
BMJ Open|September 16, 2024
Preterm birth as a determinant of neurodevelopment and cognition in children (PRENCOG): protocol for an exposure-based cohort study in the UKJames P Boardman, Ruth Andrew, Mark E Bastin, et al.
British Journal of Pharmacology|December 28, 2025
Pharmacological inhibition of hydroxysteroid 11-beta dehydrogenase type 1 (11-βHSD1) after myocardial infarction preserves cardiac function in a translational mini-pig modelSara Al Disi, Raimondo Ascione, Shazia Khan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 11, 2013
11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosisTiina Kipari, Patrick W F Hadoke, Javaid Iqbal, et al.
Hepatology (Baltimore, Md.)|May 15, 2020
Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2)Nadine Al-Naamani, Michael J Krowka, Kimberly A Forde, et al.
Scientific Reports|September 8, 2017
Carbonyl reductase 1 catalyzes 20β-reduction of glucocorticoids, modulating receptor activation and metabolic complications of obesityRuth A Morgan, Katharina R Beck, Mark Nixon, et al.
Clinical Endocrinology|January 17, 2024
Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19Kerri Devine, Clark D Russell, Giovanny R Blanco, et al.
Science Signaling|May 5, 2026
LIPID MAPS: Powering discovery in lipidomicsLauren Cockayne, Matthew J Conroy, Chetin Baloglu, et al.
Science Signaling|May 20, 2025
Technical recommendations for analyzing oxylipins by liquid chromatography-mass spectrometryNils Helge Schebb, Nadja Kampschulte, Gerhard Hagn, et al.
Pageof 14